Received: 11 May 2021
Accepted: 27 January 2022
First Online: 14 February 2022
: The Sud-Est III Committee for the Protection of Persons (Ref.CPP: 2019-039 B) studied this research project and issued a favorable opinion for its implementation. Patients will be informed in a complete and fair manner, in understandable terms, of the objectives and constraints of the study, of the possible risks incurred, of the necessary surveillance and safety measures, of their rights to refuse to participate in the study or the possibility to withdraw at any time. All this information appears on an information and consent form (Annex 2) given to the patient. The patient’s free, informed and written consent will be obtained by the investigator, or a doctor representing him, before final inclusion in the study. A copy of the information and consent form signed by both parties will be given to the patient, the investigator will keep the original.
: The scientific communications and reports matching this study will be produced under the responsibility of the principal investigator who coordinates the study with the agreement of the responsible investigators.
: The authors declare that they have no competing interests.